Rapid COVID-19 Test May Miss Large Number Of Cases

The Abbott ID test, approved by the FDA for rapid COVID-19 results, was found to miss nearly half of positive cases in a preliminary NYU study. The study, not yet peer-reviewed, deemed the test's accuracy unacceptable. Abbott questioned the study's methodology, claiming a false negative rate of 0.02% and defending the test's performance. The test is widely distributed and used by the White House, which has not commented on the study.

What is the main purpose of the Abbott ID test?

What were the findings of the study conducted by researchers at New York University regarding the Abbott test?

What implications do the study's results have for the use of the Abbott ID test in clinical settings?

How did the Abbott spokesman respond to the study's findings?

What is the significance of the false negative rate mentioned by the Abbott spokesman?